Sebastian Zach Selected Research

Basigin (Extracellular Matrix Metalloproteinase Inducer (EMMPRIN))

6/2011

Disrupting the EMMPRIN (CD147)-cyclophilin A interaction reduces infarct size and preserves systolic function after myocardial ischemia and reperfusion.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Sebastian Zach Research Topics

Disease

2	Neoplasm Metastasis (Metastasis) 08/2017 - 07/2014
1	Chronic Kidney Failure (Chronic Renal Failure) 01/2021
1	Margins of Excision 08/2017
1	Carcinoma (Carcinomatosis) 08/2017
1	Adenocarcinoma 07/2014
1	Neoplasms (Cancer) 07/2014
1	Pancreatic Neoplasms (Pancreatic Cancer) 07/2014
1	Infarction (Infarctions) 06/2011
1	Myocardial Ischemia (Ischemic Heart Diseases) 06/2011

Drug/Important Bio-Agent (IBA)

1	Remifentanil (Ultiva)FDA Link 01/2021
1	AnnexinsIBA 07/2014
1	Glucose (Dextrose)FDA LinkGeneric 07/2014
1	Gemcitabine FDA Link 07/2014
1	Adenosine Triphosphate (ATP)IBA 07/2014
1	bromopyruvateIBA 07/2014
1	Basigin (Extracellular Matrix Metalloproteinase Inducer (EMMPRIN))IBA 06/2011
1	LigandsIBA 06/2011
1	Monoclonal AntibodiesIBA 06/2011

Therapy/Procedure

1	Catheters 01/2021
1	General Anesthesia 01/2021
1	Local Anesthesia 01/2021
1	Peritoneal Dialysis 01/2021
1	Pancreaticoduodenectomy 08/2017
1	Therapeutics 07/2014
1	Heterologous Transplantation (Xenotransplantation) 07/2014